Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 6Uterine Cervical Neoplasms 4Prostatic Neoplasms 4Glioblastoma 4Squamous Cell Carcinoma of Head and Neck 3Sarcoma 3Glioma 3Brain Neoplasms 3Uterine Cervical Dysplasia 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Neuroblastoma 2Hematopoietic and Lymphatic System Neoplasm 2Hematologic Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Squamous Cell 2Atypical Squamous Cells of the Cervix 2Astrocytoma 2Unspecified Adult Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Tongue Neoplasms 1Testicular Neoplasms 1Teratoma 1Squamous Intraepithelial Lesions 1Spinal Cord Neoplasms 1Smoking Cessation 1Smoking 1Sexual Dysfunction, Physiological 1Rectal Neoplasms 1

Interventions

Fluorouracil 267Oxaliplatin 266Capecitabine 224Leucovorin 209Irinotecan 151Radiotherapy 131Bevacizumab 112Cetuximab 81Folfox protocol 48Surgical Procedures, Operative 44Radiation 41Drug Therapy 41Neoadjuvant Therapy 40Chemoradiotherapy 33Chemotherapy, Adjuvant 32Panitumumab 27XELOX 25Magnetic Resonance Spectroscopy 22Radiotherapy, Intensity-Modulated 21Floxuridine 17Biopsy 16Nivolumab 15Gemcitabine 15Early Intervention, Educational 15pembrolizumab 14Laparoscopy 14IFL protocol 14Celecoxib 14trifluridine tipiracil drug combination 13Gene Expression Profiling 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Rectal Neoplasms × Restraint, Physical × Clear all
NCT02280070 2014-10-31

RP II Study of SOX vs mFOLFOX6 in Patients With Resectable Rectal Cancer (KSCC1301).

Clinical Research Support Center Kyush

Phase 2 Unknown
110 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡